BIOMEX supplies human biosamples and diagnostic development services across Europe, operating from donor centers in three countries. The tech stack is lean—Office, Salesforce, Python—with heavy operational tooling (ATLAS, HPLC, SDS-PAGE) reflecting a biotech manufacturing and lab-services business. Current hiring momentum centers on research and healthcare roles, while active projects cluster around quality-management digitalization and process optimization, signaling a push to codify and standardize lab workflows across multiple sites.
BIOMEX is a Heidelberg-based biospecimen supplier and contract research organization (CRO) serving pharmaceutical, diagnostics, and life sciences companies. Founded in 1989, the company sources human biosamples (plasma, tissue, PBMCs, cell-free DNA) from owned donor centers in Heidelberg, Munich, and Cameroon, supplemented by a network of partner labs and study sites. Beyond biospecimen supply, BIOMEX offers bioprocessing services—cell-based assays, sequencing, cell isolation, sample processing—and in-vitro diagnostics (IvD) development support including design, validation, regulatory registration, and manufacturing. Operations span infectious diseases, oncology, hematology, and immunology verticals.
BIOMEX supplies human biospecimens (blood, plasma, tissue, PBMCs, cell-free DNA) and offers bioprocessing services including cell-based assays, sequencing, cell isolation, and in-vitro diagnostics development, validation, and manufacturing support.
BIOMEX operates owned donor centers in Heidelberg, Munich, and Cameroon (mobile center), plus an external network of laboratories, study sites, and medical experts across multiple therapeutic areas.
Other companies in the same industry, closest in size